Do Weight Loss Injections Cause Cancer?

Questions about cancer risk with GLP-1 and dual GIP/GLP-1 receptor agonists — the class that includes semaglutide and tirzepatide — most commonly focus on two areas: thyroid cancer and pancreatic cancer.

Thyroid concerns

In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumours in rodents. However, it is not established that this effect translates to humans, and regulators have assessed this data as part of the medicines' approval process. The product information for both Wegovy and Mounjaro includes relevant precautionary information, and people with a personal or family history of certain thyroid conditions are typically assessed carefully before being prescribed these medicines. Your prescriber will have considered your individual history when deciding whether the medicine is appropriate for you.

Pancreatic cancer

Concerns about a link between GLP-1 medicines and pancreatic cancer have been raised and studied. To date, large-scale clinical studies have not demonstrated a confirmed causal relationship. Pancreatitis — inflammation of the pancreas, which is a different condition — is a recognised risk that is listed in the product information, and any symptoms of severe or persistent abdominal pain should be reported to a healthcare professional promptly. The distinction between pancreatitis risk and pancreatic cancer risk is an important one, and your prescriber is best placed to discuss it in the context of your health history.

Ongoing monitoring

Both Wegovy and Mounjaro carry additional monitoring requirements (indicated by a black triangle ▼ in some countries). This means that healthcare professionals and patients are encouraged to report any suspected side effects — including unexpected ones — through your national reporting scheme (such as the UK's Yellow Card scheme). This post-market surveillance is how regulators continue to build the evidence base beyond clinical trials.

Other commonly asked questions in this area — such as whether weight loss injections cause gallstones or muscle loss — reflect the broader range of side effects people want to understand before and during treatment. Gallbladder-related effects, for instance, are a recognised area of monitoring; you can read more about weight loss injections and gallbladder problems in our dedicated guide. For a broader overview of how these medicines work and what to expect, visit our complete guide to weight loss injections.

Why nausea is more common than cancer risk

It is worth noting that the side effects most people actually experience are gastrointestinal — nausea being the most widely reported. Nausea happens because GLP-1 receptor agonists slow gastric emptying and act on appetite-regulating pathways in the brain and gut. It is typically most noticeable after a dose increase and tends to ease as the body adjusts. Serious concerns like cancer risk, while understandable to research, are a very different category from these commonly reported effects.

When you are taking a medicine with an evolving safety profile, keeping a clear record of how you feel over time has real value — both for your own peace of mind and for conversations with your prescriber or doctor.

GLP Trackr's side-effect tracker lets you log symptoms as they happen — nausea, fatigue, abdominal discomfort, or anything else you notice — and see patterns across days and weeks. Rather than trying to recall how you felt at your last appointment, you can bring a clear, timestamped picture of your experience. The app also lets you generate a summary to share with your healthcare professional, so those conversations are grounded in your actual data rather than memory.

If you ever log something that concerns you — persistent pain, unusual symptoms, or anything that feels different from your typical experience — the record in the app is a useful starting point for a prompt conversation with your prescriber. GLP Trackr helps you observe and document; it does not interpret symptoms or replace clinical assessment.

You can also explore what to consider when managing your weight loss injection journey alongside tracking your health in the app.

If you experience severe, persistent, or worrying symptoms at any point — including abdominal pain, changes you did not expect, or anything that feels urgent — contact your healthcare professional promptly. GLP Trackr is a tracking companion, not a substitute for medical advice or clinical care.

Start logging how you feel from day one — GLP Trackr is available free on the App Store and Google Play, with a 7-day trial to explore every feature. Your journey, clearly tracked.